MEIRAGTX HOLDINGS PLC (MGTX) Fundamental Analysis & Valuation

NASDAQ:MGTX • KYG596651029

7.81 USD
+0.05 (+0.64%)
At close: Mar 11, 2026
7.81 USD
0 (0%)
After Hours: 3/11/2026, 8:11:34 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MGTX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MGTX. MGTX was compared to 519 industry peers in the Biotechnology industry. MGTX may be in some trouble as it scores bad on both profitability and health. MGTX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. MGTX Profitability Analysis

1.1 Basic Checks

  • In the past year MGTX has reported negative net income.
  • MGTX had a negative operating cash flow in the past year.
  • MGTX had negative earnings in each of the past 5 years.
  • MGTX had a negative operating cash flow in each of the past 5 years.
MGTX Yearly Net Income VS EBIT VS OCF VS FCFMGTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

  • MGTX's Return On Assets of -89.03% is on the low side compared to the rest of the industry. MGTX is outperformed by 71.68% of its industry peers.
Industry RankSector Rank
ROA -89.03%
ROE N/A
ROIC N/A
ROA(3y)-40.41%
ROA(5y)-32.41%
ROE(3y)-129.61%
ROE(5y)-91.21%
ROIC(3y)N/A
ROIC(5y)N/A
MGTX Yearly ROA, ROE, ROICMGTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

  • With a decent Gross Margin value of 41.01%, MGTX is doing good in the industry, outperforming 73.99% of the companies in the same industry.
  • MGTX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MGTX Yearly Profit, Operating, Gross MarginsMGTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. MGTX Health Analysis

2.1 Basic Checks

  • MGTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MGTX has more shares outstanding than it did 1 year ago.
  • MGTX has more shares outstanding than it did 5 years ago.
  • MGTX has a worse debt/assets ratio than last year.
MGTX Yearly Shares OutstandingMGTX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MGTX Yearly Total Debt VS Total AssetsMGTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • MGTX has an Altman-Z score of -7.98. This is a bad value and indicates that MGTX is not financially healthy and even has some risk of bankruptcy.
  • MGTX has a worse Altman-Z score (-7.98) than 69.17% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.98
ROIC/WACCN/A
WACC9.5%
MGTX Yearly LT Debt VS Equity VS FCFMGTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 0.22 indicates that MGTX may have some problems paying its short term obligations.
  • The Current ratio of MGTX (0.22) is worse than 92.49% of its industry peers.
  • MGTX has a Quick Ratio of 0.22. This is a bad value and indicates that MGTX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MGTX has a Quick ratio of 0.22. This is amonst the worse of the industry: MGTX underperforms 92.49% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
MGTX Yearly Current Assets VS Current LiabilitesMGTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. MGTX Growth Analysis

3.1 Past

  • The earnings per share for MGTX have decreased by -2.93% in the last year.
  • Looking at the last year, MGTX shows a very strong growth in Revenue. The Revenue has grown by 96.83%.
  • The Revenue has been growing by 20.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-2.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.73%
Revenue 1Y (TTM)96.83%
Revenue growth 3Y-4.07%
Revenue growth 5Y20.15%
Sales Q2Q%-96.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.15% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 90.67% on average over the next years. This is a very strong growth
EPS Next Y-3.92%
EPS Next 2Y17.64%
EPS Next 3Y16.32%
EPS Next 5Y14.15%
Revenue Next Year94.29%
Revenue Next 2Y260.66%
Revenue Next 3Y118.38%
Revenue Next 5Y90.67%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MGTX Yearly Revenue VS EstimatesMGTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
MGTX Yearly EPS VS EstimatesMGTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. MGTX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MGTX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MGTX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MGTX Price Earnings VS Forward Price EarningsMGTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGTX Per share dataMGTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MGTX's earnings are expected to grow with 16.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.64%
EPS Next 3Y16.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MGTX Dividend Analysis

5.1 Amount

  • No dividends for MGTX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MGTX Fundamentals: All Metrics, Ratios and Statistics

MEIRAGTX HOLDINGS PLC

NASDAQ:MGTX (3/11/2026, 8:11:34 PM)

After market: 7.81 0 (0%)

7.81

+0.05 (+0.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13
Earnings (Next)03-12
Inst Owners53.45%
Inst Owner Change0.71%
Ins Owners4.84%
Ins Owner Change12.43%
Market Cap628.63M
Revenue(TTM)27.42M
Net Income(TTM)-168.69M
Analysts84.29
Price Target27.92 (257.49%)
Short Float %9.69%
Short Ratio13.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.36%
Min EPS beat(2)-24.05%
Max EPS beat(2)-0.66%
EPS beat(4)1
Avg EPS beat(4)-3.75%
Min EPS beat(4)-24.05%
Max EPS beat(4)12.47%
EPS beat(8)2
Avg EPS beat(8)-41.18%
EPS beat(12)4
Avg EPS beat(12)-30.49%
EPS beat(16)5
Avg EPS beat(16)-24.85%
Revenue beat(2)0
Avg Revenue beat(2)-74.5%
Min Revenue beat(2)-94.22%
Max Revenue beat(2)-54.78%
Revenue beat(4)1
Avg Revenue beat(4)272.91%
Min Revenue beat(4)-94.22%
Max Revenue beat(4)1298.04%
Revenue beat(8)2
Avg Revenue beat(8)173.75%
Revenue beat(12)3
Avg Revenue beat(12)102.95%
Revenue beat(16)6
Avg Revenue beat(16)103.42%
PT rev (1m)0%
PT rev (3m)-0.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)17.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22.93
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.11
EYN/A
EPS(NY)-1.31
Fwd EYN/A
FCF(TTM)-1.5
FCFYN/A
OCF(TTM)-1.44
OCFYN/A
SpS0.34
BVpS-0.5
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -89.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.01%
FCFM N/A
ROA(3y)-40.41%
ROA(5y)-32.41%
ROE(3y)-129.61%
ROE(5y)-91.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.18%
Cap/Sales 17.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z -7.98
F-Score4
WACC9.5%
ROIC/WACCN/A
Cap/Depr(3y)233.72%
Cap/Depr(5y)368.57%
Cap/Sales(3y)147.08%
Cap/Sales(5y)142.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.73%
EPS Next Y-3.92%
EPS Next 2Y17.64%
EPS Next 3Y16.32%
EPS Next 5Y14.15%
Revenue 1Y (TTM)96.83%
Revenue growth 3Y-4.07%
Revenue growth 5Y20.15%
Sales Q2Q%-96.24%
Revenue Next Year94.29%
Revenue Next 2Y260.66%
Revenue Next 3Y118.38%
Revenue Next 5Y90.67%
EBIT growth 1Y7.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.57%
OCF growth 3YN/A
OCF growth 5YN/A

MEIRAGTX HOLDINGS PLC / MGTX FAQ

Can you provide the ChartMill fundamental rating for MEIRAGTX HOLDINGS PLC?

ChartMill assigns a fundamental rating of 2 / 10 to MGTX.


What is the valuation status for MGTX stock?

ChartMill assigns a valuation rating of 0 / 10 to MEIRAGTX HOLDINGS PLC (MGTX). This can be considered as Overvalued.


Can you provide the profitability details for MEIRAGTX HOLDINGS PLC?

MEIRAGTX HOLDINGS PLC (MGTX) has a profitability rating of 1 / 10.


Can you provide the financial health for MGTX stock?

The financial health rating of MEIRAGTX HOLDINGS PLC (MGTX) is 0 / 10.